💊

Overview of First-Line Hypertension Therapy

Sep 17, 2024

First-Line Therapy for Hypertension

Key Players in Medication Choices

  • Understanding key classes of medications is essential for managing hypertension.

General Guidelines for First-Line Therapy

  • Patient Characteristics and Comorbidities: Consider unique patient situations and histories when prescribing.
  • Common First-Line Agents:
    • Thiazides
    • Calcium Channel Blockers
    • ACE Inhibitors (ACE-I)
    • Angiotensin Receptor Blockers (ARBs)

Thiazides

  • Often the first choice for hypertension.
  • Better at preventing heart failure compared to calcium channel blockers.
  • Consider for patients with good lifestyle choices and low sodium intake.

ACE Inhibitors and ARBs

  • Patients who require medication despite lifestyle changes may respond better to these options.
  • Recommended for:
    • Patients with albuminuria (slow progression and preserve kidney function).
    • Patients with chronic kidney disease.

Beta Blockers

  • No longer recommended as a first choice for the general population.

Special Populations

  • Diabetic Patients:

    • Same first-line options as the general population.
    • ACE-I or ARB preferred if albuminuria is present.
  • Black Patients:

    • Recommended first-line therapies: Thiazides or Calcium Channel Blockers.
    • ACE-I and ARBs less effective at preventing stroke compared to thiazides or CCBs.
  • Combination Therapy:

    • If starting two agents: ACE-I or ARB with Thiazide or CCB.
    • Avoid RAS inhibitors as a single agent, even in diabetic patients.
  • Pregnancy Considerations:

    • Limited options: Calcium Channel Blockers (e.g., Nifedipine) or Beta Blockers (e.g., Labetalol).
    • Avoid ACE-I and ARBs.
  • Recent Myocardial Infarction or Heart Failure:

    • First choice: Beta Blocker.
    • Followed by ACE-I or ARB.
  • Stable Coronary Artery Disease:

    • First: ACE-I or ARB.
    • Then consider Beta Blocker or CCB.

Gender Differences in Treatment

  • No significant differences in antihypertensive treatments or blood pressure targets between males and females.
  • Some studies indicate side effects may be more common in women.

Additional Resources

  • Encouragement to check out the course for further learning and a free trial account for access to chapters.